Form 4: Exact Sciences Director James Edward Doyle Sells 2,000 Shares
SEC Form 4
Director James Edward Doyle sold 2,000 shares of Exact Sciences Corp. on March 1, 2024, at a price of $57.5 per share.
Summary
- James Edward Doyle, a director of Exact Sciences Corp., sold 2,000 shares of common stock on March 1, 2024.
- The sale price was $57.5 per share.
- Following the transaction, Doyle directly owns 50,110 shares of Exact Sciences Corp.
- The sale was executed under a Rule 10b5-1 trading plan established on November 13, 2023.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged trading plan and doesn't necessarily indicate a positive or negative outlook on the company.
Industry Context
Sales by company directors are a normal part of corporate governance. It is important to consider the context of the sale, such as the use of a 10b5-1 trading plan, which suggests the sale was pre-planned and not based on insider information.
Stakeholder Impact
- The sale of shares by a director could have a minor impact on shareholder confidence, but the use of a 10b5-1 trading plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 11/13/2023 | Date of establishment of the Rule 10b5-1 trading plan |
| 03/01/2024 | Date of the transaction (sale of shares) |
| 03/04/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.